Article Name Europe
New approval provides French hospitals and clinics with access to a proven PSMA-PET imaging agent
29th April, 2025
The minimally invasive MINT® procedure offers a novel, sutureless solution for managing intraocular pressure in glaucoma patients.
18th April, 2025
Clinicians across the United Kingdom can now access Eko's advanced digital stethoscopes, auscultation accessories, and AI-supported tools via EkoHealth.com and Amazon UK.
16th April, 2025
New TS1200 model supports up to 300 lbs, offering hospitals a more efficient, scalable solution for surgical instrument transport and storage.
14th April, 2025
Hours, Not Days: EU Approval Accelerates 5-Hour Pathogen ID for Critical Cases. Molecular Fingerprinting: AI-Powered ‘DNA Barcode’ Spots 200+ Species, Including Uncultivable Pathogens. Hospital Laboratories Across Europe Now Have Immediate Access To a Fully Certified, Untargeted Molecular Diagnostics Platform.
11th April, 2025
Robotic-Assisted Platform Enhances Intraoperative Radiation Therapy for Neuro-Oncology and Breast Cancer Treatments
10th April, 2025
The collaboration is in line with Orexo's strategy to broaden the use of its powder-based drug delivery technology, AmorphOX®.
10th April, 2025
Collaboration Enhances Cancer Diagnostics by Integrating Advanced AI into Unified Imaging Workflows
09th April, 2025
• Osteopore secures European Union Medical Device Regulation (EU MDR) approval to supply its cutting-edge custom orthopaedic and cranial implants. • EU MDR approval unlocks opportunities to offer high-value, custom implants to Europe, in addition to off-the-shelf implants, introducing new revenue streams. • Regulatory clearance validates Osteopore’s orthopaedic and cranial products in Europe, strengthening the Company’s positioning in the market. • The European orthopaedic market is projected to grow at a CAGR of 3.3% (2029),while the cranial implant market is expected to grow at a CAGR of 9.4% (2030).
09th April, 2025
Advanced Machine Learning Tool Integrates with Shoulder Planning App to Personalize Surgical Predictions
08th April, 2025
Strategic collaboration extends TOOsonix's reach into Poland, addressing skin diseases for a population of over 37 million.
31st March, 2025
New results from the VERIFI study show Immunovia's test accurately detects 77% of early-stage cases and maintains strong specificity across diverse high-risk groups—strengthening commercial launch plans for Q3 2025.
25th March, 2025
Innovative software enhances MRI scan quality, reduces scan times by up to 80%, and optimizes radiology workflows without requiring hardware upgrades.
17th March, 2025
Zimmer Biomet Secures FDA Clearance for Persona® Revision SoluTion™ Femur, Expanding Options for Metal-Sensitive Knee Implant Patients
10th March, 2025
With cases of atrial fibrillation and other heart rhythm disorders rising rapidly, the European Heart Rhythm Association (EHRA) calls for greater awareness and early detection—starting with a simple pulse check on 1 March.
03rd March, 2025
Noor to lead strategy, M&A, and innovation initiatives, including integration of Paragon 28 acquisition.
28th February, 2025
Collaboration brings clinical-grade magnetoencephalography (MEG) technology to consumers, launching first brain health center in London.
28th February, 2025
At ECR 2025, the two companies unveil the next phase of their research program, developing scalable urine filtration systems to reduce contrast media waste and promote circular sustainability in hospital radiology.
26th February, 2025
© 2023 MM Activ Sci-Tech Communications. All rights reserved | Disclaimer